Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Zhejiang Starry Pharm Co Ltd

603520
Current price
9.48 CNY -0.13 CNY (-1.35%)
Last closed 9.61 CNY
ISIN CNE1000026N8
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Shanghai Stock Exchange
Capitalization 4 139 443 227 CNY
Yield for 12 month -41.23 %
1Y
3Y
5Y
10Y
15Y
603520
21.11.2021 - 28.11.2021

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products, such as levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is headquartered in Taizhou, China. Address: Modern Industrial Cluster Area, Taizhou, China, 317306

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

76.98 CNY

P/E ratio

235.5

Dividend Yield

Current Year

+2 201 102 024 CNY

Last Year

+2 136 205 018 CNY

Current Quarter

+689 755 286 CNY

Last Quarter

+643 796 887 CNY

Current Year

+534 569 706 CNY

Last Year

+513 645 889 CNY

Current Quarter

+143 549 674 CNY

Last Quarter

+143 088 724 CNY

Key Figures 603520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 321 524 221 CNY
Operating Margin TTM 5.87 %
PE Ratio 235.5
Return On Assets TTM 1.42 %
PEG Ratio
Return On Equity TTM 0.64 %
Wall Street Target Price 76.98 CNY
Revenue TTM 2 375 121 609 CNY
Book Value 4.58 CNY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -13.3 %
Dividend Yield
Gross Profit TTM 513 645 888 CNY
Earnings per share 0.04 CNY
Diluted Eps TTM 0.04 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -65 %
Profit Margin 0.59 %

Dividend Analytics 603520

Dividend growth over 5 years

10 %

Continuous growth

Payout Ratio 5 years average

1 %

Dividend History 603520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 09.09.2024
Forward Annual Dividend Yield
Last Split Factor 1.4:1
Payout Ratio 125 %
Last Split Date 17.06.2022
Dividend Date

Stock Valuation 603520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 235.5
Forward PE
Enterprise Value Revenue 2.5422
Price Sales TTM 1.778
Enterprise Value EBITDA 54.1645
Price Book MRQ 1.5488

Financials 603520

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 603520

For 52 weeks

7.34 CNY 16.3 CNY
50 Day MA 8.6 CNY
Shares Short Prior Month
200 Day MA 10.29 CNY
Short Ratio
Shares Short
Short Percent